Search filters

Filters
Clear All

Phase

  • 6
  • 6
  • 3
  • 6

Found 6 Endocrinology trials

A listing of Endocrinology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 RevitaT2Di Pivotal Study (REVITALIZE 1)

RevitaT2Di Pivotal Study (REVITALIZE 1)

21-70 years
All genders
The Revitalize-1 Study will look at a potential procedure called duodenal mucosal resurfacing (DMR). The DMR procedure acts on the first layer (mucosa) of the duodenum (the part of the small intestine located immediately after the stomach). By removing an excess layer, the treatment may improve blood sugar control. This …
 A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)

A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)

18-99 years
All genders
If you have type 2 diabetes and use short and long acting insulin then we would love to talk to you!   The study is being done to learn if an automated insulin delivery (AID) system can safely control blood sugar in people with type 2 diabetes. We will refer …
 Dosing of LT4 (DOT4)

Dosing of LT4 (DOT4)

65-100 years
All genders
The purpose of this study is to find the effects of taking different doses of the thyroid medication levothyroxine in older people who already take levothyroxine for hypothyroidism. Older people are more likely to have problems when their dose of levothyroxine is too strong. Allowing lower doses of levothyroxine would …

Adipose Tissue Biopsies

All genders
To help further our understanding of the best practices for collecting and processing adipose tissue samples for use in research related to obesity and the metabolism. The primary outcome is the collection of adequate adipose tissue sample. i.e., at least 1 gram, from the gluteal and abdominal sites to ensure …

CAH Treatment

All genders
To evaluate the safety and tolerability of CRN04894 Change from Baseline in morning (before 11:00 AM) serum A4 (androstenedione) at Week 12. Change from Baseline in morning (before 11:00) serum 17-OHP (17-hydroxyprogesterone) at Week 12.

INCB 00928-201

All genders
Please see full protocol, section 3, Objectives and Endpoints. Please see full protocol, section 3, Objectives and Endpoints. Please see full protocol, section 3, Objectives and Endpoints.